Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H14O5 |
Molecular Weight | 226.2259 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC=C(CO)[C@@]1([H])[C@H](O)OC=C2C(=O)OC
InChI
InChIKey=AZKVWQKMDGGDSV-BCMRRPTOSA-N
InChI=1S/C11H14O5/c1-15-10(13)8-5-16-11(14)9-6(4-12)2-3-7(8)9/h2,5,7,9,11-12,14H,3-4H2,1H3/t7-,9-,11-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24348193Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7299624 | https://www.ncbi.nlm.nih.gov/pubmed/24041312 | https://www.ncbi.nlm.nih.gov/pubmed/9827681
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24348193
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7299624 | https://www.ncbi.nlm.nih.gov/pubmed/24041312 | https://www.ncbi.nlm.nih.gov/pubmed/9827681
Genipin is an aglycone derived from an iridoid glycoside called Geniposide (structure on the bottom) present in fruit of Gardenia jasmindides Ellis. Genipin have been demonstrated to have diverse pharmacological activities including anti-inflammatory, antioxidative, neuroprotective, and neurotrophic effects. Genipin is an excellent natural cross-linker for protein, collagen, gelatin, and chitosan cross-linking and can be considered as a substitute for glutaraldehyde. Due to cross-linking properties genipin can be used in controlling drug delivery.
In addition genipin exerts choleretic action.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24972301 | https://www.ncbi.nlm.nih.gov/pubmed/27395402
Curator's Comment: Genipin is CNS active in animal studies. No human data available
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P70406 Gene ID: 22228.0 Gene Symbol: Ucp2 Target Organism: Mus musculus (Mouse) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16753577 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Harvested porcine mitral xenograft fixation: impact on fluid dynamic performance. | 2001 Jan |
|
[Studies on the cytological function of the biomembrane and the neurons]. | 2002 Oct |
|
Isolation and characterization of water-soluble intermediates of blue pigments transformed from geniposide of Gardenia jasminoides. | 2002 Oct 23 |
|
Crosslinking of biological tissues using genipin and/or carbodiimide. | 2003 Mar 1 |
|
Biocompatibility and biodegradation of a bone composite containing tricalcium phosphate and genipin crosslinked gelatin. | 2004 Jun 15 |
|
Genipin--a novel fingerprint reagent with colorimetric and fluorogenic activity. | 2004 Mar |
|
Acellular bovine pericardia with distinct porous structures fixed with genipin as an extracellular matrix. | 2004 May-Jun |
|
Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. | 2004 Oct |
|
A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. | 2005 Apr |
|
Genipin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of TNF-alpha production. | 2005 Dec |
|
Construction of varying porous structures in acellular bovine pericardia as a tissue-engineering extracellular matrix. | 2005 May |
|
Genipin, a novel fingerprint reagent with colorimetric and fluorogenic activity, part II: optimization, scope and limitations. | 2005 Nov |
|
Genipin suppresses subconjunctival fibroblast migration, proliferation and myofibroblast transdifferentiation. | 2006 |
|
Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. | 2006 Feb 20 |
|
Genipin cross-linked alginate-chitosan microcapsules: membrane characterization and optimization of cross-linking reaction. | 2006 Jul |
|
Swelling and mechanical properties of biopolymer hydrogels containing chitosan and bovine serum albumin. | 2006 Nov |
|
Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy. | 2007 |
|
Rheological study of genipin cross-linked chitosan hydrogels. | 2007 Dec |
|
Constituents of Gardenia volkensii: their brine shrimp lethality and DPPH radical scavenging properties. | 2007 Feb |
|
Application of crosslinkers to dentin collagen enhances the ultimate tensile strength. | 2007 Jan |
|
Synthesis of monoterpene alkaloid derivatives from the iridoid glucoside geniposide. | 2007 Nov |
|
Molecularly imprinted chitosan-genipin hydrogels with recognition capacity toward o-xylene. | 2007 Nov |
|
Noninvasive nuclear factor-kappaB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice. | 2007 Oct |
|
Effects of collagen crosslinking on tissue fragility. | 2008 Jan |
|
Effect of genipin on the biliary excretion of cholephilic compounds in rats. | 2008 Jun |
|
Evaluation of the release rate of bioactive recombinant human epidermal growth factor from crosslinking collagen sponges. | 2008 Mar |
|
Genipin exhibits neurotrophic effects through a common signaling pathway in nitric oxide synthase-expressing cells. | 2008 Mar 10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16169698/
Oral genipin, at dose 50 mg/kg, exerts anti-inflammatory activity in carrageenan-induced rat paw edema
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21399655
Genipin reduced the viability of K562 cells with an IC(50) value of approximately 250 μmol/L. Genipin 200-400 μmol/L induced formation of typical apoptotic bodies and DNA fragmentation.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Genipin
Created by
admin on Sat Dec 16 07:59:10 GMT 2023 , Edited by admin on Sat Dec 16 07:59:10 GMT 2023
|
PRIMARY | |||
|
A3V2NE52YG
Created by
admin on Sat Dec 16 07:59:10 GMT 2023 , Edited by admin on Sat Dec 16 07:59:10 GMT 2023
|
PRIMARY | |||
|
442424
Created by
admin on Sat Dec 16 07:59:10 GMT 2023 , Edited by admin on Sat Dec 16 07:59:10 GMT 2023
|
PRIMARY | |||
|
6902-77-8
Created by
admin on Sat Dec 16 07:59:10 GMT 2023 , Edited by admin on Sat Dec 16 07:59:10 GMT 2023
|
PRIMARY | |||
|
DTXSID30894999
Created by
admin on Sat Dec 16 07:59:10 GMT 2023 , Edited by admin on Sat Dec 16 07:59:10 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD